1 minute reading time (49 words)

BioElectronics Announces FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain

BioElectronics Corporation is pleased to announce that it has obtained a new 510(k) clearance from the U.S. Food and Drug Administration (FDA). This new, over-the counter marketing clearance was granted for the drug free ActiPatch® medical device, for the indication: "adjunctive treatment of musculoskeletal pain."

Full story

Related Posts

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More